Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : HemaCare Corporation (HEMA), profitable -- Ignore unavailable to you. Want to Upgrade?

To: TARIQ STOCKS who wrote (21)	5/27/1998 11:37:00 AM
From: Tamer	Read Replies (2) \| Respond to of 70

To all: Hema to pursue Reverse split Just recieved a response from JoAnn Stover, Director of Investor Relations and Corporate Secretary for Hema. (818-986-3883) Thought I would share it with you. Her email said: 1) if hema unable to maintain $1 bid for 10 consecutive days by 5/28, SEC will issue a delisting letter to company which will id the review procedures available to company. 2) At share holders meeting scheduled for June 29, vote will be taken to authorize a proposed reverse split. (she did not go into detail) "we are hopeful the price will increase" 3) In regards to a share buyback, hema has tangible assets of 2.4 M. A buyback would deduct cost of treasury stock from cash as well as against equity. They would then be under NASDAQ $2M equity requirement. 4) Hema intends to file an appeal with NASDAQ for an extension of the May 28 deadline based on the reverse stock split. For further information contact JoAnn. Mike